Class I
Terminated
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
This recall has been terminated (originally issued May 29, 2019).
- Company
- Novartis Pharmaceuticals Corp.
- Recall Initiated
- May 11, 2019
- Posted
- May 29, 2019
- Recall Number
- D-1309-2019
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 792 cartons
- Firm Location
- East Hanover, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Distribution
Nationwide with in the United States
Lot / Code Info
Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.
More recalls by Novartis Pharmaceuticals Corp.
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025